RE:Nice Read That's a gooden. Hopefully Theralase will get to Os-4T eventually. But whether or not, the research still increases Theralase's IP.
"Here we introduce an Os(II)-based PS (Os-4T) that is extremely potent, can be activated with near-infrared light (NIR, 733 nm), and exhibits photocytotoxic effects in hypoxia (1% O2)."